About me - Andreas CV & LinkedIn Rewrite Coaching & Consulting Reverse Recruitment Blog Shop Client Reviews Inner Circle Newsletter Email & LinkedIn AI Persona Freelance Recruitment & TA Strategy Book a Free Getting-to-Know Call
← All Articles

Ever Wonder Why Brilliant Pharma Professionals Get Overlooked by Recruiters?

Why do qualified pharma professionals get overlooked by recruiters?

It is rarely the experience or the skills. After 17 years of pharmaceutical recruitment, the consistent pattern is that exceptional candidates become invisible because their CV and LinkedIn read like alphabet soup — unstructured acronyms, no clear achievement framing, and a headline that does not match the role being applied for. A 90-minute repositioning typically does more for shortlist rate than another year of experience.

It's not their experience. It's not their skills.

It's often the bloody acronyms.

Pop quiz: What's a HEOR professional?

If you picked C, you're absolutely right.

After 17 years in pharmaceutical recruitment — 9 at Bayer and 5 in global CROs — I've seen exceptional candidates become invisible because their profiles read like alphabet soup.

It's not that they lack skills. It's that their profiles look like a game of Scrabble gone wrong.

"Experienced in MAA submissions via CTD format for EMA approval."

Sounds impressive, right? But here's the problem: many recruiters (especially those newer to pharma) and not all ATS algorithms speak fluent acronyms.

Translation for humans — and quite a few algorithms: "Experienced in Marketing Authorisation Application (MAA) submissions via Common Technical Document (CTD) format for European Medicines Agency (EMA) approval."

This way you avoid your profile being skipped. Not because you're not qualified — but because you're hidden behind industry shorthand.

This affects everyone

The fix is simple

Spell it out the first time, then use the acronym.

"Managed Clinical Research Organisation (CRO) partnerships for Phase III trials" beats "Managed CRO partnerships for PIII trials" every single time.

Your expertise deserves to be found. Don't let jargon be the gatekeeper.

Your mum probably doesn't know what CMC, GMP, or ICH stands for. Neither does half the recruiting world. And even some AI scanning your profile at 3am might have trouble too.

Spell it out once. Use the acronym after. Everyone wins.

Unless you want to remain pharma's best-kept secret?

Ready to take control of your pharma career?

Book a free getting-to-know call. I will tell you honestly where you stand, what the market looks like for your profile, and what your next move should be.

Book a Free Getting-to-Know Call

Frequently asked questions

Why do qualified pharma professionals get overlooked by recruiters?

Rarely because of the experience itself. Andreas Schulz, who spent 17 years in pharma recruitment and screened over 10,000 candidates, puts the damage at the presentation layer: a CV and LinkedIn profile that read like alphabet soup, packed with unexplained acronyms and no clear achievement framing. A line like 'Experienced in MAA submissions via CTD format for EMA approval' tells a regulatory colleague everything. To a recruiter who joined the industry last year, it says almost nothing. Applicant tracking systems have the same trouble with it. The profile gets skipped, and nobody involved ever finds out what that person could actually do.

Should I spell out acronyms like CRO, MAA or HEOR on my CV and LinkedIn profile?

Yes, on first appearance. Write the full term, put the acronym in brackets after it, then use the short form for the rest of the document. 'Managed Clinical Research Organisation (CRO) partnerships for Phase III trials' reads perfectly well to a specialist, and it also lands with someone new to pharma. HEOR is the example Schulz uses. Outside the function, very few people know it stands for Health Economics and Outcomes Research. Applicant tracking systems don't reliably expand acronyms either, so the spelled-out version gives them more to match against. The cost is a handful of extra words.

Does the acronym problem only affect junior candidates?

No. It runs through every level. Junior candidates get filtered because their profiles are thin and the few acronyms in them carry the whole story. Mid-career specialists moving between therapeutic areas have it worst, since the recruiter reading the CV often has no background in the area they're leaving behind. Senior leaders assume their track record speaks for itself, which stops being true the moment a screening algorithm or a generalist recruiter sees the profile first. Seniority buys you nothing here. The fix is identical at every stage: define the term once, then use the shorthand.

More where this came from.

Join the inner circle for exclusive pharma career intelligence, subscriber-only offers, and early access to The Ultimate Pharma Job Guide.